Evidence map›Paper›PMID 35846144›Full record

ReviewFrontiers in genetics2022

Nanomaterials in Animal Husbandry: Research and Prospects.

Kun Wang, Xubin Lu, Yi Lu, Jiacheng Wang, Qinyue Lu, Xiang Cao, Yi Yang, Zhangping Yang

Abstract readReview
In one paragraph

Review in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kun WangCollege of Animal Science and Technology, Yangzhou University, Yangzhou, China.
Xubin LuCollege of Animal Science and Technology, Yangzhou University, Yangzhou, China.
Yi LuJiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses; College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
Jiacheng WangCollege of Medical, Yangzhou University, Yangzhou, China.
Qinyue LuCollege of Animal Science and Technology, Yangzhou University, Yangzhou, China.
Xiang CaoCollege of Animal Science and Technology, Yangzhou University, Yangzhou, China.
Yi YangJiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses; College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
Zhangping YangCollege of Animal Science and Technology, Yangzhou University, Yangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anti-inflammatory, antiviral, and anti-cancer treatments are potential applications of nanomaterials in biology. To explore the latest discoveries in nanotechnology, we reviewed the published literature, focusing on co-assembled nanoparticles for anti-inflammatory and anti-tumor properties, and their applications in animal husbandry. The results show that nanoparticles have significant anti-inflammation and anti-tumor effects, demonstrating broad application prospects in animal breeding. Furthermore, pooled evidence suggests that the mechanism is to have a positive impact on inflammation and tumors through the specific drug loading by indirectly or directly targeting the disease sites. Because the precise regulatory mechanism remains unclear, most studies have focused on regulating particular sites or even specific genes in the nucleus by targeting functional co-assembled nanoparticles. Hence, despite the intriguing scenarios for nanotechnology in farmed animals, most results cannot yet be translated into field applications. Overall, nanomaterials outperformed similar materials in terms of anti-inflammatory and anti-tumor. Nanotechnology also has promising applications in animal husbandry and veterinary care, and its application and development in animal husbandry remain an exciting area of research.

Indexed as

animal medicineanti-inflammatoryantitumornanomaterialnanoparticles

Identifiers

PMID35846144
PMCPMC9280890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.